Open AccessNimotuzumab Improves Survival for KRAS Wild-Type Advanced Pancreatic Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000856140.57601.48
Subject(s) - gemcitabine , nimotuzumab , medicine , pancreatic cancer , regimen , oncology , placebo , kras , cancer , gastroenterology , surgery , pathology , epidermal growth factor receptor , colorectal cancer , alternative medicine